10 PEGINTERFERON LAMBDA-1A (LAMBDA) COMPARED TO PEGINTERFERON ALFA-2A (ALFA) IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPES (G) 2 OR 3: FIRST SVR24 RESULTS FROM EMERGE PHASE IIB Stefan Zeuzem , Sanjay Arora , Bruce R Bacon , Terry D Box , Michael R Charlton , Moises Diago , Douglas T Dieterich , Rafael Esteban Mur , Gregory T Everson , Michael B Fallon , Peter Ferenci , Robert Flisiak , James W George , Reem H Ghalib , Norman Gitlin , Andrzej Gladysz , Stuart C Gordon , S Greenbloom , Tarek Hassanein , Ira M Jacobson , Lennox J Jeffers , Kris V Kowdley , Eric J Lawitz , Samuel S Lee , Barbara A Leggett , Stefan Lueth , Deborah B Nelson , Paul J Pockros , Maribel Rodrigueztorres , Vinod K Rustgi , Lawrence Serfaty , Mark Sherman , Mitchell L Shiffman , Ricard Sola , Mark S Sulkowski , Hugo E Vargas , John M Vierling , Boris Yoffe , Laura M Ishak , David Fontana , Dehong Xu , Terri S Gray , A Horga , J Hillson , J C Lopeztalavera , A Muir Journal of Hepatology（2012）
关键词
hcv genotypes, peginterferon, first svr24 results, treatment-naive
AI 理解论文
溯源树
样例
